Byzen Digital Inc
Change company Symbol lookup
Select an option...
BYZN Byzen Digital Inc
XOM Exxon Mobil Corp
EPD Enterprise Products Partners LP
STLB Sterling Business Solutions Inc
CITY Avalon Correctional Services Inc
TEVJF Teva Pharmaceutical Industries Ltd
UMBF UMB Financial Corp
OXM Oxford Industries Inc
ICON Iconix Brand Group Inc
BAC Bank of America Corp
Go

Information Technology : IT Services |
Based in China
Company profile

Byzen Digital Inc. (formerly Emergency Pest Services Inc.) is a China-based company principally engaged in the development of a complete blockchain eco-system for Crypto requirements as its main objective. Byzen Digital Inc. has already made its first two acquisitions. Telecoin is a typical Crypto-currency company and Digi Ex is a company specialized in the marketing and promoting of Crypto-currencies. The Company help take its customers on a journey towards a much wider understanding of what Crypto and Blockchain technologies really are through its products. The Company also focuses to incorporate start-ups and small and medium-sized enterprises (SMEs) from the technology sectors, including cybersecurity, data storage, cloud-tech, analytics, software and digital applications.

Price
Delayed
$0.175
Day's Change
0.015 (9.37%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.189
Day's Low
0.151
Volume
(Heavy Day)

Today's volume of 501,754 shares is on pace to be much greater than BYZN's 10-day average volume of 898,364 shares.

501,754

Insights into the Atrial Fibrillation Industry in North America to 2027 - Featuring Boston Scientific, Medtronic & AtriCure Among Others - ResearchAndMarkets.com

12:07 pm ET April 17, 2020 (BusinessWire) Print

The "North America Atrial Fibrillation Market to 2027 - Regional Analysis and Forecasts by Treatment Type; End User, and Country" report has been added to ResearchAndMarkets.com's offering.

The North America atrial fibrillation market is expected to reach US$ 6,284.87 Mn by 2027 from US$ 2,285.69 Mn in 2019.

The atrial fibrillation market is growing primarily due to rising number of patients suffering with cardiovascular diseases, and rising awareness regarding atrial fibrillation. Restraining factor such as high cost of atrial fibrillation devices and procedures is likely to have negative impact on the growth of the market in the coming years.

Growth opportunities in the developing nations have always had major impact in the field of medicine. The rise in the cardiovascular conditions are rising across the globe, the prevalence is significantly rising in the countries of the developing nations. The incidences are rising due to the shift in the lifestyle and the other health conditions due to the change in the adoption of the modernized facilities. The modernized facilities reduced the physical activities, and the stress level among the people is also growing. Thus, these factors are leading to the cardiovascular conditions and is leading to the rising demand for the atrial fibrillation treatment.

The developing nations are significantly developing their healthcare facilities and services and are heading towards the technological advancements. For instance, structural heart is at initial stage of the development in the regions like Asia Pacific and Middle East and Africa.

For instance, in India KIM hospital provides services for the heart conditions in the south Indian region. In addition, the incidences of the AF is increasing in the North American countries. As per the report Epidemiology of AF 2019, by Biosense Webster, every year around 1.4 million new people suffer from AF. Also, according to the statistics it is expected that the incidences for the heart diseases are likely to increase in the Asian region.

Thus, the opportunities for the market players to enter the market with the cost effective products are higher. Therefore, owing to the above mentioned factors the growth of the market is likely to boost in these regions during the forecasted period.

Companies Mentioned

Boston Scientific Corporation Medtronic AtriCure, Inc BOEHRINGER INGELHEIM GMBH, Inc CardioFocus Abbott Sanofi Bristol-Myers Squibb Company Biotronik, Inc Biosense Webster, Inc.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Atrial Fibrillation market. Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends in the North America atrial fibrillation market, thereby allowing players across the value chain to develop effective long-term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. North America Atrial Fibrillation for Healthcare Market- Key Takeaways

3. Research Methodology

4. North America Atrial Fibrillation Market - Market Landscape

4.1 Overview

4.2 Market Segmentation

4.3 Pest Analysis

5. North America Atrial Fibrillation Market- Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Rising Number of Patients Suffering with Cardiovascular Diseases

5.2 Restraints

5.2.1 High Cost of Atrial Fibrillation Devices and Procedures

5.3 Key Market Opportunities

5.3.1 Growth Opportunities in The Developing Nations

5.4 Future Trends

5.4.1 Development of Novel Technologies

5.5 Impact Analysis

6. Atrial Fibrillation Market - North America Analysis

6.1 North America Atrial Fibrillation Market Revenue Forecasts and Analysis

6.2 Market Positioning

6.3 Performance of Key Players

6.3.1 Biosense Webster, Inc. (Johnson & Johnson)

6.3.2 Medtronic

7. North America Atrial Fibrillation Market Analysis - By Treatment Type

7.1 Overview

7.2 North America Atrial Fibrillation Market, By Treatment Type, 2018 & 2027 (%)

7.3 North America Atrial Fibrillation Market Revenue and Forecasts to 2027, By Product Type (Us$ Mn)

7.4 Non-Pharmacological

7.5 Non-Pharmacological Atrial Fibrillation Market Revenue and Forecast to 2027 (US$ Mn)

7.6 Pharmacological

8. North America Atrial Fibrillation Market Analysis - By End User

8.1 Overview

8.2 North America Atrial Fibrillation Market, By End User, 2018 & 2027 (%)

8.3 North America Atrial Fibrillation Market Revenue And Forecasts To 2027, By End User (Us$ Mn)

8.4 Hospitals

8.5 Ambulatory Surgical Centres

8.6 Cardiac Catheterization Laboratories

8.7 North America Atrial Fibrillation market

9. Atrial Fibrillation Market -Industry Landscape

9.1 Overview

9.1.1 Recent Developments by Players in Atrial Fibrillation Market

10. Atrial Fibrillation Market - Key Company Profiles

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/n3d5ni

View source version on businesswire.com: https://www.businesswire.com/news/home/20200417005451/en/

SOURCE: Research and Markets

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.